The standard therapy for locally advanced rectal cancers (LARCs) is neoadjuvant chemoradiation (nCRT) followed by surgical resection. Pathological response to nCRT varies among patients, and it remains a challenge to predict pathological response to nCRT in LARCs.
http://ift.tt/2DZhZnj
Παρασκευή 2 Φεβρουαρίου 2018
A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου